NCT00873288

Brief Summary

RATIONALE: Receiving a reminder letter from their doctor with questions to ask the Cancer Information Service may be more effective than a standard reminder letter in helping patients who have had an abnormal Pap test keep their follow-up colposcopy appointment. PURPOSE: This randomized clinical trial is studying a personalized letter with Cancer Information Service support to see how well it works compared with a standard reminder letter in women scheduled for colposcopy after an abnormal Pap test.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
254

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Oct 2006

Typical duration for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2006

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2008

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2008

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

March 31, 2009

Completed
1 day until next milestone

First Posted

Study publicly available on registry

April 1, 2009

Completed
14 years until next milestone

Results Posted

Study results publicly available

March 20, 2023

Completed
Last Updated

March 21, 2023

Status Verified

March 1, 2023

Enrollment Period

2.1 years

First QC Date

March 31, 2009

Results QC Date

October 4, 2016

Last Update Submit

March 17, 2023

Conditions

Keywords

cervical intraepithelial neoplasiaatypical squamous cells of undetermined significancehigh-grade squamous intraepithelial lesionlow-grade squamous intraepithelial lesion

Outcome Measures

Primary Outcomes (2)

  • Patient Satisfaction in the 2 Interventions

    Patient satisfaction with provider-patient communication was assessed via administration of the Consumer Assessment of Health Plans Study (CAHPS) satisfaction questionnaire which rates satisfaction on a 1 to 3 scale. Scores are added together, with minimum score being 4 and the maximum score being 12, with a higher score indicating greater satisfaction.

    within 6 months of PAP

  • CIS Experience of Patients in Arm II and the Effect of the Intervention on Their Follow-up Colposcopy

    within 6 months of PAP

Secondary Outcomes (3)

  • Attendance at a Follow-up Colposcopy Appointment Within 6 Months of Their Pap Test

    within 6 months of PAP

  • Latency Between the Pap Test and the Colposcopy Appointment

    within 6 months of PAP

  • Number of CIS Callers Who Provided the Specific Codes Listed in the Intervention Letter

    WITHIN 6 MONTHS OF PAP

Study Arms (2)

Usual Care mailing intervention

ACTIVE COMPARATOR

routine colposcopy reminder letter mailed

Other: Usual care mailing intervention

CIS support mailing intervention

EXPERIMENTAL

Mailed reminder plus provider recommendation to call CIS and sample questions to ask

Other: CIS support mailing intervention

Interventions

routine colposcopy reminder letter

Usual Care mailing intervention

Mailed reminder plus provider recommendation to call CIS and sample questions to ask

CIS support mailing intervention

Eligibility Criteria

Age18 Years - 100 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • DISEASE CHARACTERISTICS:
  • Received an abnormal Pap test result
  • Scheduled for a colposcopy within 6 months of their Pap test at either the Erie Family Health Center or the Prentice Ambulatory Clinic
  • PATIENT CHARACTERISTICS:
  • Female
  • Able to communicate in either English or Spanish
  • Clinic staff will review patient charts to determine eligibility
  • PRIOR CONCURRENT THERAPY:
  • Not specified

You may not qualify if:

  • \<18 years
  • unable to communicate in English or Spanish
  • no address to which a letter can be mailed

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Robert H. Lurie Comprehensive Cancer Center at Northwestern University

Chicago, Illinois, 60611-3013, United States

Location

Erie Family Health Center

Chicago, Illinois, 60622, United States

Location

Related Publications (2)

  • Cofta-Woerpel L, Randhawa V, McFadden HG, Fought A, Bullard E, Spring B. ACCISS study rationale and design: activating collaborative cancer information service support for cervical cancer screening. BMC Public Health. 2009 Dec 2;9:444. doi: 10.1186/1471-2458-9-444.

    PMID: 19951443BACKGROUND
  • Simon MA, Cofta-Woerpel L, Randhawa V, John P, Makoul G, Spring B. Using the word 'cancer' in communication about an abnormal Pap test: finding common ground with patient-provider communication. Patient Educ Couns. 2010 Oct;81(1):106-12. doi: 10.1016/j.pec.2009.11.022. Epub 2010 Jan 8.

    PMID: 20060255BACKGROUND

MeSH Terms

Conditions

Precancerous ConditionsUterine Cervical DysplasiaAtypical Squamous Cells of the CervixSquamous Intraepithelial Lesions

Condition Hierarchy (Ancestors)

NeoplasmsUterine Cervical DiseasesUterine DiseasesGenital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital DiseasesMorphological and Microscopic FindingsPathological Conditions, Signs and Symptoms

Results Point of Contact

Title
Bonnie Spring
Organization
Northwestern University

Study Officials

  • Bonnie Spring, PhD

    Robert H. Lurie Cancer Center

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director, Center for Behavior and Health

Study Record Dates

First Submitted

March 31, 2009

First Posted

April 1, 2009

Study Start

October 1, 2006

Primary Completion

November 1, 2008

Study Completion

November 1, 2008

Last Updated

March 21, 2023

Results First Posted

March 20, 2023

Record last verified: 2023-03

Locations